-
Something wrong with this record ?
Long-term stability of Onyx: is there any indication for repeated angiography after dural arteriovenous fistula embolization
R. Voldřich, D. Netuka, F. Charvát, V. Beneš
Language English Country United States
Document type Journal Article
- MeSH
- Central Nervous System Vascular Malformations diagnostic imaging therapy MeSH
- Angiography, Digital Subtraction MeSH
- Dimethyl Sulfoxide * MeSH
- Adult MeSH
- Endovascular Procedures MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Angiography MeSH
- Adolescent MeSH
- Young Adult MeSH
- Cerebral Angiography methods MeSH
- Follow-Up Studies MeSH
- Polyvinyls * MeSH
- Prospective Studies MeSH
- Recurrence MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Embolization, Therapeutic methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
OBJECTIVE: The natural course of dural arteriovenous fistulas (DAVFs) is unfavorable. Transarterial embolization with Onyx is currently the therapeutic method of choice, although the long-term stability of Onyx has been questioned. The literature reports a significant difference in the recurrence rate after complete DAVF occlusion and lacks larger series with long-term follow-up. The authors present the largest series to date with a long-term follow-up to determine the stability of Onyx, prospectively comparing magnetic resonance angiography (MRA) and digital subtraction angiography (DSA) as follow-up diagnostic methods. METHODS: Demographics, clinical symptomatology, length of follow-up, diagnostic methods, and angiographic findings of DAVFs were recorded and retrospectively evaluated in 112 patients. A prospective group of 15 patients with more than 5 years of follow-up after complete DAVF occlusion was established. All 15 patients in the prospective group underwent a clinical examination and MRA; 10 of these patients also underwent DSA. The recurrences and the correlation between the two diagnostic methods were evaluated. RESULTS: Among the 112 patients, 71 were men and 41 were women, with an average age of 60 years. Intracranial hemorrhage (40%) was the most common clinical presentation of DAVF. At the last follow-up, 73% of the patients experienced clinical improvement, 21% remained unchanged, and 6% worsened. Overall, 87.5% of the DAVFs were occluded entirely with endovascular treatment, and 93% of the DAVFs were classified as cured at the last follow-up (i.e., completely embolized DAVFs and DAVFs that thrombosed spontaneously or after Gamma Knife surgery). Two recurrences of DAVFs were recorded in the entire series. Both were first diagnosed by MRA and confirmed with DSA. The mean follow-up was 27.7 months. In the prospective group, a small asymptomatic recurrence was diagnosed. The mean follow-up of the prospective group was 96 months. CONCLUSIONS: Onyx is a stable embolic material, although recurrence of seemingly completely occluded DAVFs may develop because of postembolization hemodynamic changes that accentuate primarily graphically absent residual fistula. These residuals can be diagnosed with MRA at follow-up. The authors' data suggest that MRA could be sufficient as the follow-up diagnostic method after complete DAVF occlusion with Onyx. However, larger prospective studies on this topic are needed.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012391
- 003
- CZ-PrNML
- 005
- 20220506130041.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3171/2020.12.JNS203811 $2 doi
- 035 __
- $a (PubMed)34171837
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Voldřich, Richard $u 1Department of Neurosurgery and Neurooncology, Charles University in Prague, First Medical Faculty, Central Military Hospital; and
- 245 10
- $a Long-term stability of Onyx: is there any indication for repeated angiography after dural arteriovenous fistula embolization / $c R. Voldřich, D. Netuka, F. Charvát, V. Beneš
- 520 9_
- $a OBJECTIVE: The natural course of dural arteriovenous fistulas (DAVFs) is unfavorable. Transarterial embolization with Onyx is currently the therapeutic method of choice, although the long-term stability of Onyx has been questioned. The literature reports a significant difference in the recurrence rate after complete DAVF occlusion and lacks larger series with long-term follow-up. The authors present the largest series to date with a long-term follow-up to determine the stability of Onyx, prospectively comparing magnetic resonance angiography (MRA) and digital subtraction angiography (DSA) as follow-up diagnostic methods. METHODS: Demographics, clinical symptomatology, length of follow-up, diagnostic methods, and angiographic findings of DAVFs were recorded and retrospectively evaluated in 112 patients. A prospective group of 15 patients with more than 5 years of follow-up after complete DAVF occlusion was established. All 15 patients in the prospective group underwent a clinical examination and MRA; 10 of these patients also underwent DSA. The recurrences and the correlation between the two diagnostic methods were evaluated. RESULTS: Among the 112 patients, 71 were men and 41 were women, with an average age of 60 years. Intracranial hemorrhage (40%) was the most common clinical presentation of DAVF. At the last follow-up, 73% of the patients experienced clinical improvement, 21% remained unchanged, and 6% worsened. Overall, 87.5% of the DAVFs were occluded entirely with endovascular treatment, and 93% of the DAVFs were classified as cured at the last follow-up (i.e., completely embolized DAVFs and DAVFs that thrombosed spontaneously or after Gamma Knife surgery). Two recurrences of DAVFs were recorded in the entire series. Both were first diagnosed by MRA and confirmed with DSA. The mean follow-up was 27.7 months. In the prospective group, a small asymptomatic recurrence was diagnosed. The mean follow-up of the prospective group was 96 months. CONCLUSIONS: Onyx is a stable embolic material, although recurrence of seemingly completely occluded DAVFs may develop because of postembolization hemodynamic changes that accentuate primarily graphically absent residual fistula. These residuals can be diagnosed with MRA at follow-up. The authors' data suggest that MRA could be sufficient as the follow-up diagnostic method after complete DAVF occlusion with Onyx. However, larger prospective studies on this topic are needed.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a digitální subtrakční angiografie $7 D015901
- 650 _2
- $a cévní malformace centrálního nervového systému $x diagnostické zobrazování $x terapie $7 D020785
- 650 _2
- $a mozková angiografie $x metody $7 D002533
- 650 12
- $a dimethylsulfoxid $7 D004121
- 650 _2
- $a terapeutická embolizace $x metody $7 D004621
- 650 _2
- $a endovaskulární výkony $7 D057510
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční angiografie $7 D018810
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a polyvinyly $7 D011145
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Netuka, David $u 1Department of Neurosurgery and Neurooncology, Charles University in Prague, First Medical Faculty, Central Military Hospital; and
- 700 1_
- $a Charvát, František $u 2Department of Neuroradiology, Central Military Hospital, Prague, Czech Republic
- 700 1_
- $a Beneš, Vladimír $u 1Department of Neurosurgery and Neurooncology, Charles University in Prague, First Medical Faculty, Central Military Hospital; and
- 773 0_
- $w MED00002843 $t Journal of neurosurgery $x 1933-0693 $g Roč. 136, č. 1 (2022), s. 175-184
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34171837 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130034 $b ABA008
- 999 __
- $a ok $b bmc $g 1789825 $s 1163592
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 136 $c 1 $d 175-184 $e 20210625 $i 1933-0693 $m Journal of neurosurgery $n J Neurosurg $x MED00002843
- LZP __
- $a Pubmed-20220425